.png){kind=icon}
.png){kind=icon}
Return
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors
.png){kind=icon}
OA
AI
DOI：10.1038/s43018-024-00840-y.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Although the development of multiple primary tumors in smokers with lung cancer can be attributed to carcinogen-induced field cancerization, the occurrence of multiple tumors at presentation in individuals with EGFR-mutant lung cancer who lack known environmental exposures remains unexplained. In the present study, we identified ten patients with early stage, resectable, non-small cell lung cancer who presented with multiple, anatomically distinct, EGFR-mutant tumors. We analyzed the phylogenetic relationships among multiple tumors from each patient using whole-exome sequencing (WES) and hypermutable poly(guanine) (poly(G)) repeat genotyping as orthogonal methods for lineage tracing. In four patients, developmental mosaicism, assessed by WES and poly(G) lineage tracing, indicates a common non-germline cell of origin. In two other patients, we identified germline EGFR variants, which confer moderately enhanced signaling when modeled in vitro. Thus, in addition to germline variants, developmental mosaicism defines a distinct mechanism of genetic predisposition to multiple EGFR-mutant primary tumors, with implications for their etiology and clinical management.
Keywords:
TYROSINE KINASE DOMAIN
RESPIRATORY EPITHELIUM
FIELD CANCERIZATION
CLONAL ORIGIN
8TH EDITION
AIR SPACES
MUTATIONS
RECEPTOR
RESISTANCE
CLASSIFICATION
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
28.5
Papers:
1.2K
Citations:
1.1W